News Archive
Impax Environmental Markets NAV falls in H1
12th Aug 2024 07:17
(Sharecast News) - Environmental markets investment trust Impax Environmental Markets said on Monday that net asset value had fallen in the six months ended 30 June amid "material volatility".
Read moreBT Group welcomes Bharti Global's purchase of Altice's stake in carrier
12th Aug 2024 07:15
(Sharecast News) - BT Group welcomed news that Bharti Global had acquired Altice UK's 24.5% stake in the telecoms carrier.
Read moreSunday newspaper round-up: Taxes, BT, Taylor Swift
11th Aug 2024 10:59
(Sharecast News) - The Chancellor has ordered cabinet ministers to search for cost-cutting reforms and to gird themselves for difficult choices over government spending. It is understood that Rachel Reeves still requires £16bn to close an estimated £22bn financing gap. Taxes on capital gains, pension contributions relief and inheritances are all being considered as possible avenues to raise funds. The Chancellor however does not dismiss the possibility of tweaks to fiscal rules that would allow her to invest slightly more. - Guardian
Read moreEurope close: Shares finish week on slightly positive note
9th Aug 2024 19:01
(Sharecast News) - European shares held gains with the Stoxx 600 index nudging towards the 500 point mark at the end of a volatile week.
Read moreLondon close: Stocks end turbulent week on positive note
9th Aug 2024 16:01
(Sharecast News) - London's stock markets ended the week on a high note, after stronger-than-expected US jobless claims data on Thursday alleviated concerns about the health of the American economy.
Read moreBroker tips: FeverTree, Future, Spirax Group
9th Aug 2024 15:59
(Sharecast News) - Citi cut its price target on Fever-Tree on Friday to 950.0p from 1,115.0p citing slight model changes and an adjustment to its price-to-earnings valuation method.
Read moreDirector dealings: Gateley director makes share purchase
9th Aug 2024 15:58
(Sharecast News) - Gateley revealed on Friday that non-executive director Colin Jones had acquired 40,000 ordinary shares in the AIM-listed professional services firm.
Read moreFSB calls on home secretary to help riot-affected SMEs
9th Aug 2024 15:43
(Sharecast News) - Small business group the National Federation of Small Business implored home secretary Yvette Cooper to help facilitate fair treatment of small and medium-sized enterprises by the insurance industry in the wake of rioting that has swept Britain in the last ten days.
Read moreSector movers: Investors breathe sigh of relief after volatile week
9th Aug 2024 15:06
(Sharecast News) - Stocks finished a rough and tumble week on the up as markets at least stabilised following the volatility storm of the previous weekend.
Read moreFTSE 100 movers: Beazley gains again; Burberry in the red
9th Aug 2024 14:51
(Sharecast News) - London's FTSE 100 was up 0.3% at 8,173.07 in afternoon trade on Friday.
Read moreFTSE 250 movers: HL gains on agreed takeover
9th Aug 2024 14:32
(Sharecast News) - FTSE 250 (MCX) 20,593.19 0.41%
Read moreUS open: S&P 500 and Nasdaq on track for fourth straight losing week
9th Aug 2024 14:12
(Sharecast News) - US stocks were lower early on Friday after market participants bought the dip in the previous session
Read moreWeek ahead: UK employment and inflation data, US CPI and Trump interview in focus
9th Aug 2024 13:06
(Sharecast News) - Financial markets' focus over the coming week will be on a raft of economic data out of the UK, which will provide greater detail as to how the economy was faring around the middle of 2024.
Read moreShein looking to open UK warehouse - report
9th Aug 2024 13:04
(Sharecast News) - Chinese fast fashion giant Shein is reportedly preparing to open its first British warehouse in preparation for a £50bn listing on the London Stock Exchange.
Read moreMerck to buy drug targeting B-cell diseases for up to $1.3bn
9th Aug 2024 12:31
(Sharecast News) - Merck said on Friday that it has agreed to buy biotech firm Curon's CN201, a novel investigational clinical-stage bispecific antibody for the treatment of B-cell associated diseases, for up to $1.3bn.
Read more